Related Experiment Video
Updated: Jun 3, 2025
06:07
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.5K
Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson's Disease
1College of Arts & Sciences, Cornell University, Ithaca, NY 14853, USA.
Biomolecules
|January 8, 2025
Summary
Parkinson's disease (PD) involves mitochondrial dysfunction and alpha-synuclein (αS) aggregation. This review explores how αS impacts mitochondrial quality control, offering insights into PD pathogenesis and potential therapies.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mitochondrial health is vital for neuron survival, regulated by quality control pathways like biogenesis, dynamics, and mitophagy.
- Mitochondrial dysfunction is a key factor in Parkinson's disease (PD), a neurodegenerative disorder.
- PD-associated genes (e.g., PRKN, PINK1) and toxins (e.g., MPTP) highlight mitochondria's role in PD.
Purpose of the Study:
- To review the current understanding of the relationship between alpha-synuclein (αS) and mitochondrial quality control in Parkinson's disease.
- To highlight recent findings on how αS affects mitochondrial biogenesis, dynamics, and autophagy.
Main Methods:
- Literature review of studies on alpha-synuclein, mitochondrial quality control, and Parkinson's disease.
- Analysis of research linking genetic factors and toxins to mitochondrial dysfunction in PD.
- Synthesis of findings on αS's impact on mitochondrial pathways.
Main Results:
- Alpha-synuclein (αS) aggregation is central to PD pathology.
- αS is implicated in disrupting mitochondrial quality control mechanisms.
- Specific effects of αS on mitochondrial biogenesis, dynamics, and mitophagy are increasingly understood.
Conclusions:
- Understanding αS's influence on mitochondrial maintenance is crucial for elucidating PD pathogenesis.
- Targeting the interplay between αS and mitochondrial quality control may offer therapeutic strategies for Parkinson's disease.
Related Concept Videos
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:15Parkinson's Disease: Overview
472
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
472
01:24Parkinson's Disease: Treatment
215
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
215
01:48ATP Synthase: Mechanism
13.9K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
13.9K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:37Mitochondria
10.5K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
10.5K